In 2015 the UK Thyroid Eye Disease Amsterdam Declaration Implementation Group (TEAMeD) produced guidelines for the management of patients with Graves' orbitopathy, published by the Royal College of Physicians. Perros P, Dayan CM, Dickinson AJ, Ezra D, Estcourt S, Foley P, Hickey J, Lazarus JH, MacEwen CJ, McLaren J, Rose GE, Uddin J, Vaidya B. CONCISE GUIDANCE Management of patients with Graves' orbitopathy: initial assessment, management outside specialised
centres and referral pathways. Clinical Medicine 2015 Vol 15, No 2: 1–6).
Supplementary source data linked to the above publication can be found here:
S1: Common symptoms and signs associated with GO
S2: Diagnostic criteria for Graves' orbitopathy (derived from Bartley et al, 1996)
S3: Activity and severity assessments for patients with Graves' orbitopathy (adapted from Bartalena et al, 2008).
S4: DiaGO (Diagnosis of GO): Graves' orbitopathy clinical assessment tool
S5: Thyroid Eye Disease Early Warning Card
The original working group established in 2009 - BTF and TEDct - was joined by representatives of professional organisations in 2010: the Royal College of Physicians, the Royal College of Ophthalmologists, the Scottish Ophthalmologists Club, the Society for Endocrinology, the British OculoPlastic Surgery Society, and the British Thyroid Association.
The working group adopted the name ‘TEAMeD’ (Thyroid Eye Disease AMsterdam Declaration) Implementation Group UK.
Guided by the Amsterdam Declaration, TEAMeD has been working to improve the patient experience for people with thyroid eye disease by seeking to put in place measures to ensure patients have access to early diagnosis, appropriate treatment, skilled professionals and high standards of joint care from endocrinologists and ophthalmologists. National - and international - standards are vital to ensure that people with thyroid eye disease can be diagnosed correctly and on time and have access to the best possible treatment in specialist centres.